4.7 Article

Synthetic ionizable aminolipids induce a pH dependent inverse hexagonal to bicontinuous cubic lyotropic liquid crystalline phase transition in monoolein nanoparticles

期刊

JOURNAL OF COLLOID AND INTERFACE SCIENCE
卷 589, 期 -, 页码 85-95

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.jcis.2020.12.060

关键词

Cubosomes; Hexosomes; Ionizable aminolipid; Nanoparticles; Drug delivery; Self-assembly; Lyotropic liquid crystal; pH responsive; Monoolein

资金

  1. RMIT Vice Chancellor's Research Fellowship

向作者/读者索取更多资源

Research focused on the synthesis of nine ionizable aminolipids and their effects on monoolein (MO) lipid nanoparticles at various pH values. As the pH shifted from neutral to acidic, the mesophase of nanoparticles changed in order from L-2 to H-2 to Q(2). Systems containing heterocyclic oleates showed a transition from H-2 to Q(2) at pH 5.5-6.5.
A prospective class of materials for drug delivery is lyotropic liquid crystalline (LLC) nanoparticles, such as cubosomes and hexosomes. Efforts are being made to generate a pH dependent system, which exhibits slow release hexosomes (H-2) at physiological pH and relatively fast release cubosomes (Q(2)) at acidic disease sites such as in various cancers and bacterial infection (pH similar to 5.5-6.5). Herein, we report the synthesis of nine ionizable aminolipids, which were doped into monoolein (MO) lipid nanoparticles. Using high throughput formulation and synchrotron small angle X-ray scattering (SAXS), the effects of aminolipid structure and concentration on the mesophase of MO nanoparticles at various pHs were determined. As the pH changed from neutral to acidic, mesophases, could be formed in an order L-2 (inverse micelles) -> H-2 -> Q(2). Specifically, systems with heterocyclic oleates exhibited the H-2 to Q(2) transition at pH 5.5-6.5. Furthermore, the phase transition pH could be fine-tuned by incorporating two aminolipids into the nanoparticles. Nanoparticles with a pH dependent phase transition as described in this study may be useful as drug delivery carriers for the treatment of cancers and certain bacterial infection. (C) 2020 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据